1. Home
  2. ELEV vs EVGR Comparison

ELEV vs EVGR Comparison

Compare ELEV & EVGR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ELEV
  • EVGR
  • Stock Information
  • Founded
  • ELEV 2019
  • EVGR 2021
  • Country
  • ELEV United States
  • EVGR Malaysia
  • Employees
  • ELEV N/A
  • EVGR N/A
  • Industry
  • ELEV Biotechnology: Pharmaceutical Preparations
  • EVGR Blank Checks
  • Sector
  • ELEV Health Care
  • EVGR Finance
  • Exchange
  • ELEV Nasdaq
  • EVGR Nasdaq
  • Market Cap
  • ELEV 155.7M
  • EVGR 94.7M
  • IPO Year
  • ELEV 2021
  • EVGR 2022
  • Fundamental
  • Price
  • ELEV $0.55
  • EVGR $11.78
  • Analyst Decision
  • ELEV Strong Buy
  • EVGR
  • Analyst Count
  • ELEV 5
  • EVGR 0
  • Target Price
  • ELEV $7.80
  • EVGR N/A
  • AVG Volume (30 Days)
  • ELEV 727.3K
  • EVGR 31.7K
  • Earning Date
  • ELEV 10-31-2024
  • EVGR 10-10-2024
  • Dividend Yield
  • ELEV N/A
  • EVGR N/A
  • EPS Growth
  • ELEV N/A
  • EVGR 3.29
  • EPS
  • ELEV N/A
  • EVGR 0.28
  • Revenue
  • ELEV N/A
  • EVGR N/A
  • Revenue This Year
  • ELEV N/A
  • EVGR N/A
  • Revenue Next Year
  • ELEV N/A
  • EVGR N/A
  • P/E Ratio
  • ELEV N/A
  • EVGR $42.29
  • Revenue Growth
  • ELEV N/A
  • EVGR N/A
  • 52 Week Low
  • ELEV $0.36
  • EVGR $11.02
  • 52 Week High
  • ELEV $5.83
  • EVGR $11.78
  • Technical
  • Relative Strength Index (RSI)
  • ELEV 37.53
  • EVGR 83.03
  • Support Level
  • ELEV $0.50
  • EVGR $11.65
  • Resistance Level
  • ELEV $0.56
  • EVGR $11.71
  • Average True Range (ATR)
  • ELEV 0.04
  • EVGR 0.00
  • MACD
  • ELEV 0.02
  • EVGR 0.01
  • Stochastic Oscillator
  • ELEV 44.22
  • EVGR 100.00

About ELEV Elevation Oncology Inc. Common stock

Elevation Oncology Inc is an oncology company focused on the development of targeted therapeutics for the treatment of cancer in genomically defined patient populations. Its lead program is focused on neuregulin-1, or NRG1, fusions, which are rare genomic alterations that have the potential to be therapeutically actionable through targeted HER3 inhibition.

About EVGR Evergreen Corporation

Evergreen Corp is a blank check company.

Share on Social Networks: